Literature DB >> 1645852

Characterization and mapping of melatonin receptors in the brain of three mammalian species: rabbit, horse and sheep. A comparative in vitro binding study.

B Stankov1, B Cozzi, V Lucini, P Fumagalli, F Scaglione, F Fraschini.   

Abstract

Melatonin receptors were characterized in the brains of three mammals (rabbit, horse and sheep) by an in vitro binding technique, using 2-[125I]iodomelatonin as labelled ligand. Although binding sites for melatonin have been described recently in several vertebrate species (including the sheep), the rabbit and the horse have not been the subject of investigation so far. Apart from characterization, the present report describes receptor distribution in a number of brain regions, thus allowing for direct interspecies comparison under the same methodological conditions. 2-[125I]iodomelatonin labelled high-affinity binding sites in crude membrane preparations from these species. A series of kinetic and saturation experiments revealed that the binding was rapid, stable, saturable, reversible, of high affinity (Kd in the low picomolar range) and low capacity (Bmax between 1 and 20 fmol/mg protein). The competition studies showed that the relative order of potency of a variety of indoles for inhibition of 2-[125I]iodomelatonin binding was as follows: 2-iodomelatonin greater than 6-chloromelatonin greater than melatonin much much greater than 5-methoxytryptophol greater than 5-methoxytryptamine, and that it was similar in the different brain regions. Prazosin, which has been reported as an extremely potent melatonin analog in the hamster brain, possessed no potency in all preparations from different regions in the three species under investigation. The regional distribution of the receptor showed insignificant species differences. Highest density was always recorded in the median eminence/pars tuberalis (ME/PT) area. Other regions (SCN, POA and certain cortical areas), showed lower, but significant, receptor content. Saturation and competition studies revealed that these binding sites were also of high affinity, low capacity and high specificity.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1645852     DOI: 10.1159/000125721

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  11 in total

1.  Ligand efficacy and potency at recombinant human MT2 melatonin receptors: evidence for agonist activity of some mt1-antagonists.

Authors:  R Nonno; M Pannacci; V Lucini; D Angeloni; F Fraschini; B M Stankov
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

Review 2.  Influence of melatonin and photoperiod on animal and human reproduction.

Authors:  A Cagnacci; A Volpe
Journal:  J Endocrinol Invest       Date:  1996-06       Impact factor: 4.256

3.  Melatonin reduces low-Mg2+ epileptiform activity in human temporal slices.

Authors:  J D Fauteck; J Bockmann; T M Böckers; W Wittkowski; R Köhling; A Lücke; H Straub; E J Speckmann; I Tuxhorn; P Wolf
Journal:  Exp Brain Res       Date:  1995       Impact factor: 1.972

4.  Hypothalamic involvement in chronic migraine.

Authors:  M F Peres; M Sanchez del Rio; M L Seabra; S Tufik; J Abucham; J Cipolla-Neto; S D Silberstein; E Zukerman
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-12       Impact factor: 10.154

5.  Effect of photoperiod and exogenous melatonin on correlates of estrus in the domestic rabbit.

Authors:  R Hudson; A I Melo; G González-Mariscal
Journal:  J Comp Physiol A       Date:  1994-11       Impact factor: 1.836

6.  Photoperiod-dependent changes in exocytotic activity in the hypophyseal pars tuberalis of the Djungarian hamster, Phodopus sungorus.

Authors:  T Merks; A Schulze-Bonhage; W Wittkowski
Journal:  Cell Tissue Res       Date:  1993-08       Impact factor: 5.249

7.  Distribution of 2-[I]iodomelatonin binding in the brain of Mexican free-tailed bats (Tadarida brasiliensis).

Authors:  Christine Schwartz; Paul Bartell; Vincent Cassone; Michael Smotherman
Journal:  Brain Behav Evol       Date:  2009-02-18       Impact factor: 1.808

8.  Melatonin.

Authors:  Paul Pévet
Journal:  Dialogues Clin Neurosci       Date:  2002-03       Impact factor: 5.986

9.  Melatonin in animal models.

Authors:  Paul Pévet
Journal:  Dialogues Clin Neurosci       Date:  2003-12       Impact factor: 5.986

10.  Can melatonin prevent or improve metabolic side effects during antipsychotic treatments?

Authors:  Maria-Cristina Porfirio; Juliana Paula Gomes de Almeida; Maddalena Stornelli; Silvia Giovinazzo; Diane Purper-Ouakil; Gabriele Masi
Journal:  Neuropsychiatr Dis Treat       Date:  2017-08-10       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.